Galectin Therapeutics Inc financial data

Symbol
GALT on Nasdaq
Industry
Pharmaceutical Preparations
Location
4960 Peachtree Industrial Boulevard, Suite 240, Norcross, GA
State of incorporation
NV
Fiscal year end
December 31
Former names
PRO PHARMACEUTICALS INC (to 5/26/2011)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 112 % -39.4%
Debt-to-equity -126 % +9.59%
Return On Equity 52.9 % -31.8%
Return On Assets -188 % -3.86%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 63.2M shares +2.06%
Common Stock, Shares, Outstanding 63.2M shares +2.11%
Entity Public Float 112M USD +77.8%
Common Stock, Value, Issued 62K USD +1.64%
Weighted Average Number of Shares Outstanding, Basic 62.3M shares +3.57%
Weighted Average Number of Shares Outstanding, Diluted 62.3M shares +3.57%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 36.6M USD +13.8%
General and Administrative Expense 5.86M USD -1.35%
Operating Income (Loss) -42.4M USD -11.5%
Nonoperating Income (Expense) -4.61M USD -54.1%
Net Income (Loss) Attributable to Parent -47M USD -14.6%
Earnings Per Share, Basic -0.76 USD/shares -2.7%
Earnings Per Share, Diluted -0.76 USD/shares -2.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 15.1M USD -41.1%
Assets, Current 17.3M USD -37.7%
Property, Plant and Equipment, Net 0 USD
Operating Lease, Right-of-Use Asset 16K USD -65.2%
Other Assets, Noncurrent 243K USD -50.4%
Assets 17.5M USD -38%
Accounts Payable, Current 5.66M USD -12.1%
Employee-related Liabilities, Current 1.52M USD +34.9%
Accrued Liabilities, Current 8.2M USD -10.7%
Liabilities, Current 35.4M USD +126%
Operating Lease, Liability, Noncurrent 7K USD -87.3%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 121M USD +36.3%
Retained Earnings (Accumulated Deficit) -402M USD -13.3%
Stockholders' Equity Attributable to Parent -105M USD -69.1%
Liabilities and Equity 17.5M USD -38%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.1M USD -12.2%
Net Cash Provided by (Used in) Financing Activities 10M USD 0%
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 63.2M shares +2.11%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 15.1M USD -41.1%
Deferred Tax Assets, Valuation Allowance 90.3M USD +15.2%
Deferred Tax Assets, Gross 90.3M USD +15.2%
Operating Lease, Liability 19K USD -71.2%
Lessee, Operating Lease, Liability, to be Paid 19K USD -72.5%
Property, Plant and Equipment, Gross 74K USD 0%
Operating Lease, Liability, Current 19K USD -58.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 19K USD +5.56%
Lessee, Operating Lease, Liability, to be Paid, Year One 20K USD -60.8%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 0 USD -100%
Deferred Tax Assets, Operating Loss Carryforwards 63.1M USD +2.65%
Preferred Stock, Shares Issued 1.24M shares 0%
Preferred Stock, Shares Authorized 1.74M shares 0%
Additional Paid in Capital 296M USD +1.5%
Preferred Stock, Shares Outstanding 1.24M shares 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 2.45M USD +8.23%
Interest Expense 3.38M USD +167%